206 related articles for article (PubMed ID: 35416080)
1. Advances in Head and Neck Cancer Pain.
Ye Y; Jensen DD; Viet CT; Pan HL; Campana WM; Amit M; Boada MD
J Dent Res; 2022 Aug; 101(9):1025-1033. PubMed ID: 35416080
[TBL] [Abstract][Full Text] [Related]
2. Towards neuroimmunotherapy for cancer: the neurotransmitters glutamate, dopamine and GnRH-II augment substantially the ability of T cells of few head and neck cancer patients to perform spontaneous migration, chemotactic migration and migration towards the autologous tumor, and also elevate markedly the expression of CD3zeta and CD3epsilon TCR-associated chains.
Saussez S; Laumbacher B; Chantrain G; Rodriguez A; Gu S; Wank R; Levite M
J Neural Transm (Vienna); 2014 Aug; 121(8):1007-27. PubMed ID: 25030361
[TBL] [Abstract][Full Text] [Related]
3. MEK1/2 inhibition transiently alters the tumor immune microenvironment to enhance immunotherapy efficacy against head and neck cancer.
Prasad M; Zorea J; Jagadeeshan S; Shnerb AB; Mathukkada S; Bouaoud J; Michon L; Novoplansky O; Badarni M; Cohen L; Yegodayev KM; Tzadok S; Rotblat B; Brezina L; Mock A; Karabajakian A; Fayette J; Cohen I; Cooks T; Allon I; Dimitstein O; Joshua B; Kong D; Voronov E; Scaltriti M; Carmi Y; Conde-Lopez C; Hess J; Kurth I; Morris LGT; Saintigny P; Elkabets M
J Immunother Cancer; 2022 Mar; 10(3):. PubMed ID: 35292516
[TBL] [Abstract][Full Text] [Related]
4. miR145 targets the SOX9/ADAM17 axis to inhibit tumor-initiating cells and IL-6-mediated paracrine effects in head and neck cancer.
Yu CC; Tsai LL; Wang ML; Yu CH; Lo WL; Chang YC; Chiou GY; Chou MY; Chiou SH
Cancer Res; 2013 Jun; 73(11):3425-40. PubMed ID: 23548270
[TBL] [Abstract][Full Text] [Related]
5. Bone marrow mesenchymal stem cells promote head and neck cancer progression through Periostin-mediated phosphoinositide 3-kinase/Akt/mammalian target of rapamycin.
Liu C; Feng X; Wang B; Wang X; Wang C; Yu M; Cao G; Wang H
Cancer Sci; 2018 Mar; 109(3):688-698. PubMed ID: 29284199
[TBL] [Abstract][Full Text] [Related]
6. Perspectives in Pain Research 2014: Neuroinflammation and glial cell activation: The cause of transition from acute to chronic pain?
Cairns BE; Arendt-Nielsen L; Sacerdote P
Scand J Pain; 2015 Jan; 6(1):3-6. PubMed ID: 29911589
[TBL] [Abstract][Full Text] [Related]
7. CXCR3 isoform A promotes head and neck cancer progression by enhancing stem-like property and chemoresistance.
Sun WH; Peng TJ; Tang SJ; Lin JY; Wang CY; Fang HJ; Sun KH
J Oral Pathol Med; 2022 Oct; 51(9):791-800. PubMed ID: 35998229
[TBL] [Abstract][Full Text] [Related]
8. Is pain part of a systemic syndrome in head and neck cancer?
Bossi P; Ghiani M; Argenone A; Depenni R
Support Care Cancer; 2020 Feb; 28(2):451-459. PubMed ID: 31713692
[TBL] [Abstract][Full Text] [Related]
9. A novel p38-MAPK signaling axis modulates neutrophil biology in head and neck cancer.
Dumitru CA; Fechner MK; Hoffmann TK; Lang S; Brandau S
J Leukoc Biol; 2012 Apr; 91(4):591-8. PubMed ID: 22262799
[TBL] [Abstract][Full Text] [Related]
10. Tumor-neuroglia interaction promotes pancreatic cancer metastasis.
Su D; Guo X; Huang L; Ye H; Li Z; Lin L; Chen R; Zhou Q
Theranostics; 2020; 10(11):5029-5047. PubMed ID: 32308766
[No Abstract] [Full Text] [Related]
11. Schwann Cells Induce Phenotypic Changes in Oral Cancer Cells.
Santi MD; Zhang M; Salvo E; Asam K; Viet CT; Xie T; Amit M; Aouizerat B; Ye Y
Adv Biol (Weinh); 2022 Sep; 6(9):e2200187. PubMed ID: 35925609
[TBL] [Abstract][Full Text] [Related]
12. Epithelial-mesenchymal transition transcription factor ZEB1/ZEB2 co-expression predicts poor prognosis and maintains tumor-initiating properties in head and neck cancer.
Chu PY; Hu FW; Yu CC; Tsai LL; Yu CH; Wu BC; Chen YW; Huang PI; Lo WL
Oral Oncol; 2013 Jan; 49(1):34-41. PubMed ID: 22892238
[TBL] [Abstract][Full Text] [Related]
13. Autocrine and paracrine loops between cancer cells and macrophages promote lymph node metastasis via CCR4/CCL22 in head and neck squamous cell carcinoma.
Tsujikawa T; Yaguchi T; Ohmura G; Ohta S; Kobayashi A; Kawamura N; Fujita T; Nakano H; Shimada T; Takahashi T; Nakao R; Yanagisawa A; Hisa Y; Kawakami Y
Int J Cancer; 2013 Jun; 132(12):2755-66. PubMed ID: 23180648
[TBL] [Abstract][Full Text] [Related]
14. Tumor-derived macrophage migration inhibitory factor modulates the biology of head and neck cancer cells via neutrophil activation.
Dumitru CA; Gholaman H; Trellakis S; Bruderek K; Dominas N; Gu X; Bankfalvi A; Whiteside TL; Lang S; Brandau S
Int J Cancer; 2011 Aug; 129(4):859-69. PubMed ID: 21328346
[TBL] [Abstract][Full Text] [Related]
15. Elucidation of pathophysiology and treatment of neuropathic pain.
Vranken JH
Cent Nerv Syst Agents Med Chem; 2012 Dec; 12(4):304-14. PubMed ID: 23033930
[TBL] [Abstract][Full Text] [Related]
16. Long non-coding RNA implicated in the invasion and metastasis of head and neck cancer: possible function and mechanisms.
Luo X; Qiu Y; Jiang Y; Chen F; Jiang L; Zhou Y; Dan H; Zeng X; Lei YL; Chen Q
Mol Cancer; 2018 Jan; 17(1):14. PubMed ID: 29368602
[TBL] [Abstract][Full Text] [Related]
17. Alterations in opioid inhibition cause widespread nociception but do not affect anxiety-like behavior in oral cancer mice.
Ye Y; Bernabé DG; Salvo E; Viet CT; Ono K; Dolan JC; Janal M; Aouizerat BE; Miaskowski C; Schmidt BL
Neuroscience; 2017 Nov; 363():50-61. PubMed ID: 28673713
[TBL] [Abstract][Full Text] [Related]
18. Intraoperative electroacupuncture relieves remifentanil-induced postoperative hyperalgesia via inhibiting spinal glial activation in rats.
Shi C; Liu Y; Zhang W; Lei Y; Lu C; Sun R; Sun Y; Jiang M; Gu X; Ma Z
Mol Pain; 2017; 13():1744806917725636. PubMed ID: 28825338
[TBL] [Abstract][Full Text] [Related]
19. The paracrine effect of cancer-associated fibroblast-induced interleukin-33 regulates the invasiveness of head and neck squamous cell carcinoma.
Chen SF; Nieh S; Jao SW; Wu MZ; Liu CL; Chang YC; Lin YS
J Pathol; 2013 Oct; 231(2):180-9. PubMed ID: 23775566
[TBL] [Abstract][Full Text] [Related]
20. Legumain Induces Oral Cancer Pain by Biased Agonism of Protease-Activated Receptor-2.
Tu NH; Jensen DD; Anderson BM; Chen E; Jimenez-Vargas NN; Scheff NN; Inoue K; Tran HD; Dolan JC; Meek TA; Hollenberg MD; Liu CZ; Vanner SJ; Janal MN; Bunnett NW; Edgington-Mitchell LE; Schmidt BL
J Neurosci; 2021 Jan; 41(1):193-210. PubMed ID: 33172978
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
